Sponsored by:
Ensuring Consistency and Reliability in Post-Discovery Bioanalysis with TaqPath™ General Purpose Reagents
Have you experienced inconsistent real-time PCR (qPCR) product performance and obstacles during post-discovery bioanalysis and quality control (QC) assay developmen
Have you experienced inconsistent real-time PCR (qPCR) product performance and obstacles during post-discovery bioanalysis and quality control (QC) assay development? Applied Biosystems™ TaqPath™ general purpose reagents (GPRs) are specifically designed to address these challenges, offering stringent manufacturing QC, exceptional performance, and comprehensive compliance documentation support. These reagents, manufactured in an ISO 13485-certified and FDA-registered facility that adheres to CGMP principles, deliver consistent results and reliability for CGMP-manufactured products.
Key features include rigorous lot-to-lot consistency, tolerance to PCR inhibitors in clinical samples, and supply chain dependability with dual-site manufacturing. TaqPath GPRs enhance post-discovery QC and bioanalysis efficiency, saving time and addressing regulatory compliance challenges. Compliance documentation is easily accessible, and change control notifications are available via a one-click web sign-up. Visit thermofisher.com/qualtrak for the complete qPCR offerings from Thermo Fisher Scientific.